XML 38 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDER'S EQUITY
9 Months Ended
Oct. 31, 2011
STOCKHOLDER'S EQUITY
15.  STOCKHOLDER’S EQUITY
 
In the quarter ended April 30, 2011, the Company issued 1,350,000 common shares, bringing the total outstanding shares to 28,985,774. A total of 350,000 shares were issued to Kanehoe Advisors and 1,000,000 shares were issued in connection with the acquisition of Aligned Healthcare Group, Inc. (see Note 17). The 1,350,000 shares were valued at $273,000 based on the fair value of shares at issuance date.
 
On Aug 2, 2011, Apollo Medical Holdings, Inc. ("Apollo") acquired Pulmonary Critical Care Management, Inc. ("PCCM"), a provider of management services to the Los Angeles Lung Center, as well as the formation of its new Division of Pulmonary and Critical Care Medicine. In exchange for a 100% ownership interest in PCCM, Apollo issued 350,000 common shares to the shareholders of PCCM. The 350,000 shares were valued at $70,000 based on the fair value of shares at issuance date.

Warrants outstanding

No warrants were issued by the Company during the nine-months ended October 31, 2011.

   
Aggregate
   
Number of
 
   
intrinsic value
   
warrants
 
Outstanding at January 31, 2011
 
$
-
     
1,655,333
 
Granted
   
-
     
-
 
Exercised
   
-
     
-
 
Cancelled
   
-
     
(113,333
                 
Outstanding at October 31, 2011
 
$
-
     
1,542,000
 

           
Weighted average
         
Weighted
 
     
Warrants
   
remaining
   
Warrants
   
Weighted average
 
Exercise Price
   
outstanding
   
contractual life
   
Exercisable
   
exercise price
 
$
1.500
     
42,000
     
0.03
     
42,000
   
$
1.50
 
$
0.125
     
1,250,000
     
3.00
     
1,250,000
   
$
0.125
 
$
0.125
     
250,000
     
3.00
     
250,000
   
$
0.125
 
 

 
Options outstanding

Stock option transactions under the Company’s stock option plans for the nine-months ended October 31, 2011 are summarized below:

         
Weighted
         
         
Average
         
         
Per Share
 
Weighted Average
     
         
Exercise
 
Remaining
 
Aggregate
 
   
Shares
   
Price
 
Contractual Term
 
Intrinsic Value
 
Balance, January 31, 2011
   
1,150,000
   
$
0.15
       
-
 
Granted
   
-
     
-
           
Exercised
   
-
     
-
           
Expired
   
-
     
-
           
Forfeited
   
-
     
-
           
Balance, October 31, 2011
   
1,150,000
   
$
0.15
 
9.1 years
 
$
12,833
 
                           
Exercisable, October 31, 2011
   
666,616
   
$
0.15
 
9.1 years
 
$
12,833
 

The Company did not issue any stock options during the nine-months ended October 31, 2011 and 2010, respectively.